Enlivex Therapeutics Ltd Cash Flow-to-Debt Ratio
Enlivex Therapeutics Ltd cash flow-to-debt ratio. Enlivex Therapeutics Ltd (ENLV) has a Cash Flow-to-Debt Ratio of -0.66x as of September 2025, meaning its operating cash flow of ILA-2.30 Million could theoretically repay -1% of its total liabilities (ILA3.46 Million) in one year. See how financially flexible is Enlivex Therapeutics Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Enlivex Therapeutics Ltd (2012–2024)
Cash flow-to-debt ratio of Enlivex Therapeutics Ltd from 2012 to 2024. Historical debt coverage capacity for Enlivex Therapeutics Ltd across 13 annual periods. Check ENLV cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Enlivex Therapeutics Ltd Cash Flow-to-Debt Ratio by Year (2012–2024)
Enlivex Therapeutics Ltd cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for Enlivex Therapeutics Ltd. For the full cash flow conversion analysis, see Enlivex Therapeutics Ltd cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.17x | ILA-13.01 Million | ILA4.10 Million | ▲ +9.0% |
| 2023 | -3.49x | ILA-23.52 Million | ILA6.75 Million | ▼ -57.2% |
| 2022 | -2.22x | ILA-23.95 Million | ILA10.80 Million | ▼ -27.8% |
| 2021 | -1.74x | ILA-17.54 Million | ILA10.11 Million | ▲ +23.2% |
| 2020 | -2.26x | ILA-11.01 Million | ILA4.87 Million | ▼ -101.5% |
| 2019 | -1.12x | ILA-7.04 Million | ILA6.28 Million | ▲ +52.9% |
| 2018 | -2.38x | ILA-3.16 Million | ILA1.33 Million | ▲ +82.8% |
| 2017 | -13.81x | ILA-6.35 Million | ILA460.00K | ▼ -72.2% |
| 2016 | -8.02x | ILA-15.49 Million | ILA1.93 Million | ▼ -56.4% |
| 2015 | -5.13x | ILA-13.25 Million | ILA2.58 Million | ▼ -165.1% |
| 2014 | -1.93x | ILA-4.41 Million | ILA2.28 Million | ▲ +70.7% |
| 2013 | -6.60x | ILA-865.00K | ILA131.00K | ▼ -259.0% |
| 2012 | -1.84x | ILA-149.00K | ILA81.00K | — |